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Patients and treatments
92 volunteer patients on optimally suppressive antiviral
combinations for 5 months or more consented to step
wisely reduce their weekly treatment from 7 to 5 to
4 days/wk, or directly from 7 to 4 d/wk after bi-monthly
checks on HIV plasma levels at < 50 copies. Weekly
treatment was further reduced to 3, 2, and 1 d/wk for
respectively 72, 59 and 12 pts. Antiviral combinations
included : one integrase inhibitor-base + 2 or 3 NRTIs,
or 1 NNRTI and 1 PI (for 4 d/wk regimens, (Rx); stan-
dard triple combinations of 1 PI or 1 NNRTI +
2 NRTIs (for 4, 3 , 2 d/wk Rx); novel quadruple antiviral
compositions of 1 NNRTI + 3 NRTIs (for 4, 3 , 2, 1
d/wk Rx).
Results
Intermittent treatment fully controlled patients’ HIV
over 20 592 treatment-weeks. Of the 92 patients at
entry, 88, 66 and 51 had sustained 52 weeks with 3, 4 or
5 weekly days off-treatment periods respectively. Lym-
phocyte surface activation markers or cell-bound HIV
DNA levels remained stable or declined further; CD4/
CD8 ratios rose to ≥1 in 37% of patients – versus 7%
patients before discontinuous treatment.
Viral failures: 13 viral escapes (plasma HIV RNA >50
copies 4 weeks apart; overall failures 3.3 per 100 discontin-
uous treatment-years) were countered by prompt re-
adjustments with 7 day-a-week effective combinations. In
retrospect 10 failures were ascribable to physician’s or
patients’ errors or blunders: base-drug prescribed at sub
(½) optimal daily dosage (3 pts); overlooked archival resis-
tant HIVs from antecedent treatment failures (5 pts);
acute erratic observance (2 pts); HIV inadvertently
resurged while on a 5 day off (2 pts) or 6 days off-
treatment period, all 3 under one quadruple combination,
setting the antiviral power limit of the ultra-short treat-
ment modality with that combination at 1.4 failures per
100 proper treatment-years.
Conclusion
discontinuous maintenance therapy in 92 patients on
ARV 4 days a week and less over an average 219 treat-
ment-weeks (median 131) offered 40 to 85 % medicinal
cuts.
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